Helicobacter pylori infection in functional dyspepsia

Area of Science:

• Gastroenterology
• Microbiology
• Clinical Medicine

Background:

• Functional dyspepsia (FD) is a prevalent condition characterized by chronic epigastric pain and discomfort.
• Helicobacter pylori (H. pylori) infection is a potential multifactorial cause of FD, leading to gastric mucosal inflammation, altered motility, and sensitivity.
• Gastritis associated with H. pylori may also impact endocrine functions, affecting gastrointestinal hormone and neurotransmitter production.

Purpose of the Study:

• To critically evaluate the clinical evidence supporting the hypothesis that H. pylori infection contributes to functional dyspepsia symptoms.
• To assess the efficacy of H. pylori eradication therapy in providing long-term symptom relief for FD patients.

Main Methods:

• A Cochrane review was conducted to analyze the effects of H. pylori eradication therapy versus placebo in patients with FD.
• The review examined symptom relief duration and efficacy across different FD symptom subtypes and patient demographics.

Main Results:

• H. pylori eradication therapy demonstrated a small but statistically significant long-term improvement in FD symptoms compared to placebo, with effects lasting at least 12 months post-treatment.
• The efficacy of eradication therapy was consistent across all FD symptom subtypes.
• A notable difference in efficacy was observed, with greater benefit seen in Asian patients compared to Western patients.

Conclusions:

• The findings support H. pylori eradication as a recommended treatment for FD patients who test positive for the bacterium.
• Current major international guidelines have been updated to include H. pylori eradication as a therapeutic option for FD.
• Further evaluation is warranted to fully confirm the causal link between H. pylori-induced abnormalities and FD symptom generation.